A detailed history of Rockefeller Capital Management L.P. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 10,938 shares of RDY stock, worth $831,834. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,938
Previous 16,656 34.33%
Holding current value
$831,834
Previous $1.16 Million 30.74%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$67.36 - $77.59 $385,164 - $443,659
-5,718 Reduced 34.33%
10,938 $802,000
Q4 2023

Feb 14, 2024

BUY
$64.27 - $69.9 $1.07 Million - $1.16 Million
16,656 New
16,656 $1.16 Million
Q3 2022

Nov 02, 2022

SELL
$49.9 - $57.32 $6,536 - $7,508
-131 Reduced 76.61%
40 $2,000
Q2 2022

Aug 12, 2022

BUY
$49.62 - $58.13 $8,485 - $9,940
171 New
171 $9,000
Q1 2022

May 13, 2022

SELL
$48.27 - $65.25 $1,448 - $1,957
-30 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$59.5 - $67.25 $833 - $941
-14 Reduced 31.82%
30 $1,000
Q3 2021

Nov 12, 2021

BUY
$60.19 - $75.29 $1,745 - $2,183
29 Added 193.33%
44 $2,000
Q2 2021

Aug 10, 2021

SELL
$62.12 - $74.2 $8,945 - $10,684
-144 Reduced 90.57%
15 $1,000
Q1 2021

May 11, 2021

BUY
$57.98 - $73.08 $9,218 - $11,619
159 New
159 $9,000
Q4 2020

Feb 12, 2021

SELL
$62.61 - $71.29 $11,520 - $13,117
-184 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$51.39 - $72.41 $9,455 - $13,323
184 New
184 $12,000
Q4 2019

Feb 07, 2020

SELL
$36.66 - $41.78 $3,299 - $3,760
-90 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$36.05 - $42.76 $3,244 - $3,848
90 New
90 $3,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $12.6B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.